Followers | 806 |
Posts | 30081 |
Boards Moderated | 5 |
Alias Born | 03/22/2016 |
Saturday, February 17, 2024 5:59:33 AM
Recent APLT News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 11:17:44 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:13:13 AM
- Applied Therapeutics Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/09/2024 11:00:00 AM
- Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference • GlobeNewswire Inc. • 05/07/2024 11:00:00 AM
- Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer • GlobeNewswire Inc. • 04/15/2024 11:00:00 AM
- Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024 • GlobeNewswire Inc. • 04/04/2024 11:00:00 AM
- Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia • GlobeNewswire Inc. • 03/28/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 12:17:35 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/06/2024 12:19:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 12:12:11 PM
- Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results • GlobeNewswire Inc. • 03/06/2024 12:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/05/2024 10:42:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:18:44 PM
- Applied Therapeutics Announces $100 Million Private Placement • GlobeNewswire Inc. • 02/28/2024 01:05:00 PM
- Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/22/2024 07:26:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 12:07:35 PM
- Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency • GlobeNewswire Inc. • 02/15/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/15/2024 02:20:37 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/13/2024 09:34:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 10:02:48 PM
- Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy • GlobeNewswire Inc. • 01/04/2024 09:05:00 PM
- Applied Therapeutics Shares Hit 52-Week High on Govorestat Filings • Dow Jones News • 01/03/2024 04:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 02:15:42 PM
- Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat (AT-007) for Treatment of Classic Galactosemia • GlobeNewswire Inc. • 01/03/2024 12:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM